Clinical Trial Update: Accuracy of VABB Elite 10G Versus BARD 14G CNB [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing accuracy of VABB Elite 10G versus BARD 14G core needle biopsy in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BARD 14G (null)
• VABB Elite 10G (null)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN